Cite
HARVARD Citation
Paulus, A. et al. (n.d.). AT‐101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia. British journal of haematology. pp. 352-365. [Online].